{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:24:27Z","timestamp":1791404667520,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.plefa.2003.12.020","type":"journal-article","created":{"date-parts":[[2004,3,12]],"date-time":"2004-03-12T10:20:40Z","timestamp":1079086840000},"page":"383-390","source":"Crossref","is-referenced-by-count":78,"title":["Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum"],"prefix":"10.1016","volume":"70","author":[{"given":"A.J","family":"Richardson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.plefa.2003.12.020_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/plef.2000.0184","article-title":"Fatty acid metabolism in neurodevelopmental disorder","volume":"63","author":"Richardson","year":"2000","journal-title":"Prostaglandius Leukot Essent Fatty Acids"},{"issue":"4","key":"10.1016\/j.plefa.2003.12.020_BIB2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/ajcn\/62.4.761","article-title":"Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder","volume":"62","author":"Stevens","year":"1995","journal-title":"Am. J. Clin. Nutr."},{"issue":"4\u20135","key":"10.1016\/j.plefa.2003.12.020_BIB3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0031-9384(95)02207-4","article-title":"Omega-3 fatty acids in boys with behavior, learning, and health problems","volume":"59","author":"Stevens","year":"1996","journal-title":"Physiol. Behav."},{"issue":"1\u20132","key":"10.1016\/j.plefa.2003.12.020_BIB4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1054\/plef.2000.0195","article-title":"Dyslexia in adults is associated with clinical signs of fatty acid deficiency","volume":"63","author":"Taylor","year":"2000","journal-title":"Prostaglandius Leukot Essent Fatty Acids"},{"key":"10.1016\/j.plefa.2003.12.020_BIB5","doi-asserted-by":"crossref","unstructured":"J.G. Bell, et al., Apparent fatty acid deficiency in autistic spectrum disorders, Prostaglandius Leukot Essent Fatty Acids, 2004, in press.","DOI":"10.1016\/j.plefa.2004.03.008"},{"issue":"8","key":"10.1016\/j.plefa.2003.12.020_BIB6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/000992288702600805","article-title":"Clinical characteristics and serum essential fatty acid levels in hyperactive children","volume":"26","author":"Mitchell","year":"1987","journal-title":"Clin. Pediatr. Phila."},{"issue":"1","key":"10.1016\/j.plefa.2003.12.020_BIB7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/plef.2001.0281","article-title":"Plasma fatty acid levels in autistic children","volume":"65","author":"Vancassel","year":"2001","journal-title":"Prostaglandius Leukot Essent Fatty Acids"},{"issue":"7","key":"10.1016\/j.plefa.2003.12.020_BIB8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1099-1492(199710)10:7<309::AID-NBM484>3.0.CO;2-0","article-title":"Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy","volume":"10","author":"Richardson","year":"1997","journal-title":"NMR Biomed."},{"issue":"1\u20132","key":"10.1016\/j.plefa.2003.12.020_BIB9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1054\/plef.2000.0189","article-title":"Increased levels of cytosolic phospholipase A2 in dyslexics","volume":"63","author":"MacDonell","year":"2000","journal-title":"Prostaglandius Leukot Essent Fatty Acids"},{"issue":"5","key":"10.1016\/j.plefa.2003.12.020_BIB10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0306-9877(81)90014-1","article-title":"Alack of essential fatty acids as a possible cause of hyperactivity in children","volume":"7","author":"Colquhoun","year":"1981","journal-title":"Med. Hypotheses"},{"issue":"8971","key":"10.1016\/j.plefa.2003.12.020_BIB11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(95)92269-5","article-title":"Benefit of docosahexaenoic acid supplements to dark adaptation in dyslexics","volume":"346","author":"Stordy","year":"1995","journal-title":"Lancet"},{"issue":"1 Suppl","key":"10.1016\/j.plefa.2003.12.020_BIB12","doi-asserted-by":"crossref","first-page":"323S","DOI":"10.1093\/ajcn\/71.1.323S","article-title":"Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia","volume":"71","author":"Stordy","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"issue":"1\u20132","key":"10.1016\/j.plefa.2003.12.020_BIB13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1054\/plef.2000.0186","article-title":"Red blood cell fatty acid compositions in a patient with autistic spectrum disorder","volume":"63","author":"Bell","year":"2000","journal-title":"Prostaglandius Leukot Essent Fatty Acids"},{"key":"10.1016\/j.plefa.2003.12.020_BIB14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1192\/bjp.179.4.286","article-title":"Are randomised controlled trials the only gold that glitters?","volume":"179","author":"Slade","year":"2001","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.plefa.2003.12.020_BIB15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00916467","article-title":"The effects of essential fatty acid supplementation by Efamol in hyperactive children","volume":"15","author":"Aman","year":"1987","journal-title":"J. Abnorm. Child Psychol."},{"issue":"2","key":"10.1016\/j.plefa.2003.12.020_BIB16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0006-3223(89)90167-4","article-title":"Gamma-linolenic acid for attention-deficit hyperactivity disorder","volume":"25","author":"Arnold","year":"1989","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.plefa.2003.12.020_BIB17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jn\/119.1.15","article-title":"Brain cell and tissue recovery in rats made deficient in n-3 fatty acids by alteration of dietary fat","volume":"119","author":"Bourre","year":"1989","journal-title":"J. Nutr."},{"issue":"2","key":"10.1016\/j.plefa.2003.12.020_BIB18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/cap.2000.10.111","article-title":"Does zinc moderate essential fatty acid and amphetamine treatment of attention-deficit\/hyperactivity disorder?","volume":"10","author":"Arnold","year":"2000","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.plefa.2003.12.020_BIB19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0753-3322(02)00253-6","article-title":"The importance of the ratio of omega-6\/omega-3 essential fatty acids","volume":"56","author":"Simopoulos","year":"2002","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.plefa.2003.12.020_BIB20","unstructured":"J.R. Burgess, Attention deficit hyperactivity disorder: observational and interventional studies, in: NIH Workshop on Omega-3 Essential Fatty Acids and Psychiatric Disorders. National Institutes of Health, Bethesda, 1998."},{"issue":"10","key":"10.1016\/j.plefa.2003.12.020_BIB21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s11745-006-1155-0","article-title":"EFA supplementation in children with inattention, hyperactivity and other disruptive behaviours","volume":"38","author":"Stevens","year":"2003","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.plefa.2003.12.020_BIB22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mpd.2001.116050","article-title":"A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit\/hyperactivity disorder","volume":"139","author":"Voigt","year":"2001","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.plefa.2003.12.020_BIB23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0920-9964(00)00083-9","article-title":"Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia","volume":"49","author":"Peet","year":"2001","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.plefa.2003.12.020_BIB24","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1176\/appi.ajp.160.5.996","article-title":"A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression","volume":"160","author":"Marangell","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.plefa.2003.12.020_BIB25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/1469-7610.00742","article-title":"The comorbidity of ADHD in the general population of Swedish school-age children","volume":"42","author":"Kadesjo","year":"2001","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"3","key":"10.1016\/j.plefa.2003.12.020_BIB26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.plefa.2003.12.020_BIB27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"Adose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.plefa.2003.12.020_BIB28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega 3 fatty acids in bipolar disorder","volume":"56","author":"Stoll","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.plefa.2003.12.020_BIB29","unstructured":"S. Hirayama, T. Hamazaki, K. Terasawa, The Effect of Foods Containing DHA on Symptoms of Attention-deficit Hyperactivity Disorder: A Randomised Controlled Trial, ISSFAL Meeting, Montreal, 2002."},{"issue":"2","key":"10.1016\/j.plefa.2003.12.020_BIB30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0278-5846(01)00254-8","article-title":"A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties","volume":"26","author":"Richardson","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2003.12.020_BIB31","series-title":"Conners\u2019 Parent Rating Scales\u2014Revised","author":"Conners","year":"1997"},{"key":"10.1016\/j.plefa.2003.12.020_BIB32","series-title":"Phospholipid Spectrum Disorders in Psychiatry and Neurology","first-page":"491","article-title":"Clinical trials of fatty acid supplementation in Dyslexia and Dyspraxia","author":"Richardson","year":"2003"},{"key":"10.1016\/j.plefa.2003.12.020_BIB33","series-title":"Phospholipid Spectrum Disorders in Psychiatry and Neurology","year":"2003"},{"issue":"1","key":"10.1016\/j.plefa.2003.12.020_BIB34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","article-title":"E-E-Multicentre-Study-Group, A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms","volume":"36","author":"Peet","year":"2002","journal-title":"J. Psychiatry Res."},{"issue":"4","key":"10.1016\/j.plefa.2003.12.020_BIB35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0924-977X(03)00032-4","article-title":"Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial","volume":"13","author":"Su","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.plefa.2003.12.020_BIB36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archpsyc.57.7.715","article-title":"The effects of olive oil on omega3 fatty acids and mood disorders","volume":"57","author":"Puri","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.plefa.2003.12.020_BIB37","first-page":"931","article-title":"Enzymatic synthesis of oleamide (cis-9, 10-octadecenoamide), an endogenous sleep-inducing lipid, by rat brain microsomes","volume":"40","author":"Sugiura","year":"1996","journal-title":"Biochem. Mol. Biol. Int."},{"issue":"5216","key":"10.1016\/j.plefa.2003.12.020_BIB38","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.7770779","article-title":"Chemical characterization of a family of brain lipids that induce sleep","volume":"268","author":"Cravatt","year":"1995","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.plefa.2003.12.020_BIB39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/138161280404221010152220","article-title":"Oleamide","volume":"4","author":"Boger","year":"1998","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.plefa.2003.12.020_BIB40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/exnr.2001.7792","article-title":"Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats","volume":"172","author":"Huitron-Resendiz","year":"2001","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.plefa.2003.12.020_BIB41","first-page":"332","article-title":"Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems","volume":"299","author":"Fedorova","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327804000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327804000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T03:19:43Z","timestamp":1682651983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327804000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0952327804000109"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2003.12.020","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}